Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bioanalysis|December 4, 2013
Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologiesJoanne Goodman, Balaji Agoram
Bioanalysis|November 7, 2024
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterionMarianne Scheel Fjording, Joanne Goodman, Chad Briscoe
Vaccine|December 6, 2021
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in miceRichard Stebbings, Gillian Armour, Vivian Pettis, et al.
Bioanalysis|January 25, 2020
European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindsetMatthew Barfield, Joanne Goodman, John Hood, et al.
Bioanalysis|April 24, 2020
European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation periodPhilip Timmerman, Joanne Goodman, Michaela Golob, et al.
European Journal of Pharmacology|March 17, 2015
Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonistDennis Sprecher, Miles Maxwell, Joanne Goodman, et al.
Bioanalysis|October 29, 2019
EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assaysSusanne Pihl, Barry Wa van der Strate, Michaela Golob, et al.
Bioanalysis|September 19, 2018
EBF recommendation on practical management of critical reagents for PK ligand-binding assaysSusanne Pihl, Barry Wa van der Strate, Michaela Golob, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 29, 2021
Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in miceRichard Stebbings, Shaun Maguire, Gillian Armour, et al.
Bioanalysis|October 7, 2020
Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practiceJoanne Goodman, Kyra J Cowan, Michaela Golob, et al.
Pageof 3